BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27613576)

  • 1. Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer.
    Mukherjee I; Powell B; Parianos M; Downs D; Ross SB
    Cancer Genet; 2016 Dec; 209(12):582-591. PubMed ID: 27613576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs in the treatment of pancreatic cancer.
    Mahalingam D; Kelly KR; Swords RT; Carew J; Nawrocki ST; Giles FJ
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):311-28. PubMed ID: 19466902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the management of pancreatic cancer: surgery is not enough.
    Ansari D; Gustafsson A; Andersson R
    World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.
    Dong M; Nio Y; Yamasawa K; Toga T; Yue L; Harada T
    J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New challenges in perioperative management of pancreatic cancer.
    Puleo F; Maréchal R; Demetter P; Bali MA; Calomme A; Closset J; Bachet JB; Deviere J; Van Laethem JL
    World J Gastroenterol; 2015 Feb; 21(8):2281-93. PubMed ID: 25741134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
    Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
    Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic ultrasound staging and novel therapeutics for pancreatic cancer.
    Owens DJ; Savides TJ
    Surg Oncol Clin N Am; 2010 Apr; 19(2):255-66. PubMed ID: 20159514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Biology: Toward Early Detection of Pancreatic Cancer.
    Gupta MK; Sarojamma V; Reddy MR; Shaik JB; Vadde R
    Crit Rev Oncog; 2019; 24(2):191-198. PubMed ID: 31679213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized drug screening based on next generation sequencing and patient derived xenograft model for pancreatic cancer with bone metastasis.
    Guan Z; Lan H; Chen X; Jiang X; Wang X; Jin K
    Mol Med Rep; 2017 Oct; 16(4):4784-4790. PubMed ID: 28849200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
    Tanaka S
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S197-205. PubMed ID: 25749932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan Experience.
    Friedman K; Resnick MB; Safran H
    R I Med J (2013); 2015 Oct; 98(10):16-20. PubMed ID: 26422540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
    Matsuoka T; Yashiro M
    World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Novel Treatment Strategy for Pancreatic Cancer Based on Gene Profiles].
    Hayashi H; Nishihara H
    Gan To Kagaku Ryoho; 2016 Nov; 43(11):1326-1331. PubMed ID: 27899773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic anomalies of pancreatic carcinoma and clinical applications].
    Pantalone D; Pelo E; Minuti B; Mazza E; Nesi G; Falchini M; Ragionieri I; Pantalone F; Torricelli F
    Clin Ter; 2001; 152(3):189-96. PubMed ID: 11692539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
    Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
    Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer.
    Kruglyak KM; Lin E; Ong FS
    Adv Exp Med Biol; 2016; 890():123-36. PubMed ID: 26703802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant/neoadjuvant chemoradiation for gastric and pancreatic cancer.
    Lowy AM; Leach SD
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):121-30. PubMed ID: 10550836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.